Cargando…
Nonlethal Inhibition of Gut Microbial Trimethylamine N‐oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure
BACKGROUND: Patients at increased risk for coronary artery disease and adverse prognosis during heart failure exhibit increased levels of circulating trimethylamine N‐oxide (TMAO), a metabolite formed in the metabolism of dietary phosphatidylcholine. We investigated the efficacy of dietary withdrawa...
Autores principales: | Organ, Chelsea L., Li, Zhen, Sharp, Thomas E., Polhemus, David J., Gupta, Nilaksh, Goodchild, Traci T., Tang, W. H. Wilson, Hazen, Stanley L., Lefer, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660847/ https://www.ncbi.nlm.nih.gov/pubmed/32390485 http://dx.doi.org/10.1161/JAHA.119.016223 |
Ejemplares similares
-
Reply: Tolerating Large Preclinical Models of HFpEF But Without the Intolerance?
por: Sharp, Thomas E., et al.
Publicado: (2021) -
Gut microbe-derived metabolite trimethylamine N-oxide activates PERK to drive fibrogenic mesenchymal differentiation
por: Kim, Seok-Jo, et al.
Publicado: (2022) -
Combination Sodium Nitrite and Hydralazine Therapy Attenuates Heart Failure With Preserved Ejection Fraction Severity in a “2‐Hit” Murine Model
por: LaPenna, Kyle B., et al.
Publicado: (2023) -
Combined Angiotensin Receptor–Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure
por: Trivedi, Rishi K., et al.
Publicado: (2018) -
Zofenopril Protects Against Myocardial Ischemia–Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability
por: Donnarumma, Erminia, et al.
Publicado: (2016)